Cyclosporin A in the treatment of acute exacerbation of idiopathic pulmonary fibrosis

Internal Medicine

Volumn 49, Issue 2, 2010, Pages 109-115

  Sakamoto, Susumu ^a,b   Homma, Sakae ^a   Miyamoto, Atsushi ^b   Kurosaki, Atsuko ^b   Fujii, Takeshi ^b   Yoshimura, Kunihiko ^b  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

Acute exacerbation; Corticosteroids; Cyclosporin A; Idiopathic pulmonary fibrosis

Indexed keywords

CYCLOSPORIN A; METHYLPREDNISOLONE;

AGED; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG PULSE THERAPY; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MALE; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL TIME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CYCLOSPORINE; DISEASE PROGRESSION; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 75749105882     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.2359     Document Type: Article

References (29)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161: 646-664, 2000.
2. Yoshimura K, Nakatani T, Nakamori N, et al. Acute exacerbation in idiopathic interstitial pneumonia. Nihon Kyobu Shikkan Gakkai Zasshi 22: 1012-1020, 1984 (abstract in English).
3. Taguchi Y. Acute exacerbation of idiopathic pulmonary fibrosis (IPF). Nihon Kokyuki Gakkai Zasshi 42: 28-31, 2004 (abstract in English).
4. Akira M, Hamada H, Sakatani M, et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR 168: 79-83, 1997.
5. Kondoh Y, Taniguchi H, Kawabata Y, et al. Acute exacerbation in idiopathic pulmonary fibrosis: Analysis of clinical and pathologic findings in three cases. Chest 103: 1808-1812, 1993.
6. The Japanese Respiratory Society. Idiopathic Interstitial Pneumonias: Diagnosis and Treatment. The Japanese Respiratory Society. Nankodo, Tokyo, 2004: 36-40 [in Japanese].
7. Collard HR, Moore BB, Flaherty KR, et al. Idiopathic pulmonary fibrosis clinical research network investigators. Acute exacerbation in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176: 636-643, 2007.
8. Maeda K, Komuta K, Kuritani T, Igarashi T. Cyclosporine treatment for interstitial pneumonitis associated with dermatomyositis/ polymyositis. Intern Med 37: 103-108, 1998.
9. Ogasawara H, Murashima A, Kaneko H, et al. Effect of low-dose cyclosporin treatment on interstitial pneumonitis associated with Sjogren's syndrome. Br J Rheumatol 37: 348-349, 1998.
10. Ogasawara H, Sekiya M, Murashima A, et al. Very low-dose cyclosporin treatment of steroid-resistant interstitial pneumonitis associated with Sjogren's syndrome. Clin Rheumatol 17: 160-162, 1998.
11. Nawata Y, Kurasawa K, Takabayashi K, et al. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J Rheumatol 6: 1527-1533, 1999.
12. Miyake S, Ohtani Y, Sawada M, et al. Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis. Sarcoidosis Vasc Diffuse Lung Dis 19: 128-133, 2002.
13. Kurasawa K, Nawata Y, Takabayashi K, et al. Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis. Clin Exp Immunol 129: 541-548, 2002.
14. Inase N, Sawada M, Ohtani Y, et al. Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid. Intern Med 42: 565-570, 2003.
15. Homma S, Sakamoto S, Kawabata M, et al. Cyclosporin treatment in steroid-resistant and acutely exacerbated interstitial pneumonia. Intern Med 44: 1144-1150, 2005.
16. Kazerooni EA, Martinez FJ, Flint A, et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol 169: 977-983, 1997.
17. Akira M, Kozuka T, Yamamoto S, Sakatani M. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 178: 372-378, 2008.
18. Souza CA, Müller NL, Flint J, Wright JL, Churg A. Idiopathic pulmonary fibrosis: spectrum of high-resolution CT findings. AJR Am J Roentgenol 185: 1531-1539, 2005.
19. Rice AJ, Wells AU, Bouros D, et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias: an autopsy study. Am J Clin Pathol 119: 709-714, 2003.
20. Ambrosini V, Cancellieri A, Chilosi M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J 22: 821-826, 2003.
21. Dallari R, Foglia M, Paci M, Cavazza A. Acute exacerbation of idiopathic pulmonary fibrosis. Eur Respir J 23: 792, 2004.
22. Sakamoto S, Homma S, Kawabata M, et al. Fatal acute exacerbation of idiopathic pulmonary fibrosis/usual interstitial pneumonia initially in the right lung after surgery lobectomy for left lung cancer. Nihon Kokyuki Gakkai Zasshi 42: 760-766, 2004 (abstract in English).
23. Parambil JG, Myers JL, Ryu JH. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest 128: 3310-3315, 2005.
24. Kondoh Y, Taniguchi H, Kitaichi M, et al. Acute exacerbation of interstitial pneumonia following surgical lung biopsy. Respir Med 100: 1753-1759, 2006.
25. Ho S, Clipstone N, Timmermann L, et al. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 80 (3 Pt 2): S40-S45, 1996.
26. Jonat C, Rahmsdorf HJ, Park KK. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62: 1189-1204, 1990.
27. Alton EW, Johnson M, Turner-Warwick M. Advanced cryptogenic fibrosing alveolitis: preliminary report on treatment with cyclosporin A. Respir Med 83: 277-279, 1989.
28. Moolman JA, Bardin PG, Rossouw DJ, Joubert JR. Cyclosporin as a treatment for interstitial lung disease of unknown aetiology. Thorax 46: 592-595, 1991.
29. Okamoto T, Ichiyasu H, Ichikado K, et al. Clinical analysis of the acute exacerbation in patients with idiopathic pulmonary fibrosis. Nihon Kokyuki Gakkai Zasshi 44: 359-367, 2006 (abstract in English).